Drug-Induced Impulse Control Disorders: A Prospectus for Neuroethical Analysis

被引:0
|
作者
Adrian Carter
Polly Ambermoon
Wayne D. Hall
机构
[1] The University of Queensland,School of Population Health
[2] The University of Queensland,University of Queensland Centre for Clinical Research
[3] The University of Queensland,Queensland Brain Institute
来源
Neuroethics | 2011年 / 4卷
关键词
Addiction; Neuroethics; Dopamine agonists; Parkinson’s Disease; Impulse control disorders; Moral responsibility;
D O I
暂无
中图分类号
学科分类号
摘要
There is growing evidence that dopamine replacement therapy (DRT) used to treat Parkinson’s Disease can cause compulsive behaviours and impulse control disorders (ICDs), such as pathological gambling, compulsive buying and hypersexuality. Like more familiar drug-based forms of addiction, these iatrogenic disorders can cause significant harm and distress for sufferers and their families. In some cases, people treated with DRT have lost their homes and businesses, or have been prosecuted for criminal sexual behaviours. In this article we first examine the evidence that these disorders are caused by DRT. If it is accepted that DRT cause compulsive or addictive behaviours in a significant minority of individuals, then the following ethical and clinical questions arise: Under what circumstances is it ethical to prescribe a medication that may induce harmful compulsive behaviours? Are individuals treated with DRT morally responsible and hence culpable for harmful or criminal behaviour related to their medication? We conclude with some observations of the relevance of DRT-induced ICDs for our understanding of addiction and identify some promising directions for future research and ethical analysis.
引用
收藏
页码:91 / 102
页数:11
相关论文
共 50 条
  • [41] DRUG-INDUCED MOVEMENT DISORDERS
    NORTH, RR
    POSTGRADUATE MEDICINE, 1971, 50 (03) : 180 - &
  • [42] DRUG-INDUCED DISORDERS OF THE LIVER
    DAVIS, M
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1980, 24 (01): : 17 - &
  • [43] Drug-induced pulmonary disorders
    Takafuji, S
    Nakagawa, T
    INTERNAL MEDICINE, 2004, 43 (03) : 169 - 170
  • [44] Drug-induced movement disorders
    JimenezJimenez, FJ
    GarciaRuiz, PJ
    Molina, JA
    DRUG SAFETY, 1997, 16 (03) : 180 - 204
  • [45] Drug-induced autoimmune disorders
    Krohn, K
    Bennett, R
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1998, 18 (04) : 897 - +
  • [46] Drug-Induced Bone Disorders
    Sweeney, Brooke L.
    CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM, 2005, 3 (01): : 75 - 92
  • [47] DRUG-INDUCED ENDOCRINE DISORDERS
    EVERED, D
    YEO, PPB
    DRUGS, 1977, 13 (05) : 353 - 365
  • [48] DRUG-INDUCED DISORDERS OF TASTE
    GRIFFIN, JP
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1992, 11 (04): : 229 - 239
  • [49] DRUG-INDUCED BLOOD DISORDERS
    不详
    MEDICAL JOURNAL OF AUSTRALIA, 1973, 2 (22) : 995 - 996
  • [50] Drug-induced musculoskeletal disorders
    Bannwarth, Bernard
    DRUG SAFETY, 2007, 30 (01) : 27 - 46